Table 2. Antimicrobial susceptibility of MRSA isolates recovered from veterinary conference attendees, Baltimore, Maryland, USA, June 3–5, 2005*.
PFGE type |
No. |
Susceptible isolates, n (%) |
---|---|---|
Mupirocin | Erythromycin | Ciprofloxacin | Tetracycline | Gentamicin | Rifampin | TMP/SMX | ||
---|---|---|---|---|---|---|---|---|
CMRSA-2 | 13 | 13 (100) | 1 (7.7) | 2 (15) | 13 (100) | 12 (92) | 13 (100) | 13 (100) |
CMRSA-5 | 13 | 13 (100) | 6 (46) | 12 (92) | 2 (15) | 3 (23) | 8 (62) | 3 (23) |
Other | 1 | 0 | 0 | 0 | 1 (100) | 1 (100) | 1 (100) | 1 (100) |
Total | 27 | 26 (96) | 7 (26) | 14 (52) | 16 (59) | 16 (59) | 22 (81) | 17 (63) |
*MRSA, methicillin-resistant Staphylococcus aureus; PFGE, pulsed-field gel electrophoresis; TMP/SMX, trimethoprim/sulfamethoxazole; CMRSA, Canadian epidemic MRSA.